Swainsonine producing performance of Alternaria oxytropis was improved by heavy-ion mutagenesis technology

FEMS Microbiol Lett. 2021 May 11;368(8):fnab047. doi: 10.1093/femsle/fnab047.

Abstract

Swainsonine, an indolizidine alkaloid, is a promising anti-tumorigenic compound. Biological production of swainsonine was prospective, but the low swainsonine yield of wild type Alternaria oxytropis limited its production on a large scale. In present work, a stable A. oxytropis mutant UO1 with swanisonine yield of 14.84% higher than the wild-type strain was successfully obtained after heavy-ion irradiation. The A. oxytropis mutant UO1 and original wild-type strain were futher evaluated for SW concentrations under different factors. Results showed that the optimum culture temperature was 25°C. The optimum initial medium pH was 6.5 and the optimum inoculum size was 2 mL per 200 mL. Addition of the biosynthetic precursor L-pipecolic acids and L-lysine appropriately could increase the SW synthesis. These findings provided a theoretical basis and scientific data for the industrial production of swainsonine.

Keywords: Alternaria oxytropis; heavy-ion; irradiation; mutagenesis; mutant; swainsonine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternaria / genetics
  • Alternaria / metabolism*
  • Culture Media
  • Heavy Ions
  • Industrial Microbiology*
  • Mutagenesis
  • Swainsonine / metabolism*

Substances

  • Culture Media
  • Swainsonine

Supplementary concepts

  • Alternaria oxytropis